D

Denali Therapeutics
D

DNLI

20.870
USD
0.64
(3.16%)
مغلق
حجم التداول
44,832
الربح لكل سهم
-3
العائد الربحي
-
P/E
-7
حجم السوق
3,259,025,057
أصول ذات صلة المقالات

العنوان: Denali Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brainpenetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.